Circulating tumor DNA for breast cancer: Review of active clinical trials
Authors:
Open Access
- 11 July 2022
- journal article
- research article
- Published by Elsevier in Cancer Treatment and Research Communications
- Vol. 32, 100609
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Assessing the Impact of Circulating Tumor DNA (ctDNA) in Patients With Colorectal Cancer: Separating Fact From FictionFrontiers in Oncology, 2018
- Mutation Analysis of Cell-Free DNA and Single Circulating Tumor Cells in Metastatic Breast Cancer Patients with High Circulating Tumor Cell CountsClinical Cancer Research, 2017
- Inferring expressed genes by whole-genome sequencing of plasma DNANature Genetics, 2016
- Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principleAnnals of Oncology, 2014
- Breast cancer chemopreventionExpert Review of Anticancer Therapy, 2012
- Circulating tumour cells in cancer patients: challenges and perspectivesTrends in Molecular Medicine, 2010
- Detection of PIK3CA mutations in circulating free DNA in patients with breast cancerBreast Cancer Research and Treatment, 2010
- Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variationsProceedings of the National Academy of Sciences of the United States of America, 2003
- Point mutations of the N‐ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemiaBritish Journal of Haematology, 1994
- Neoplastic Characteristics of the DNA Found in the Plasma of Cancer PatientsOncology, 1989